Newsroom

Categories: Drug Discovery & Development, Corporate, Finance & Investor, biopharma

New CRO from China joins Repositive Cancer Model network, increasing model database size by 87%

January 21, 2021

Categories: COVID-19, Drug Discovery & Development, Corporate, Finance & Investor

Syntekabio and Hanmi Science join forces to co-develop new promising COVID-19 treatments using drug repurposing technologies

January 19, 2021

Categories: Drug Discovery & Development

Ubiquigent and the University of York Awarded a grant to explore the potential of deubiquitylase (DUB) enzyme inhibitors to address neglected tropical diseases

January 14, 2021

Categories: Bioprocessing, Biomanufacturing, Drug Discovery & Development

New controlled-rate freezers provide optimal sample protection and support GMP and 21 CFR part 11 requirements

January 11, 2021

Categories: Research, Drug Discovery & Development

Sygnature Discovery invests £3m to expand high-throughput screening and translational oncology capabilites

December 16, 2020

Categories: Drug Discovery & Development, Manufacturing

Lonza’s MODA-EM™ paperless solution to be implemented at the UK’s new vaccines manufacturing and innovation centre

December 8, 2020

Categories: Biotechnology, Drug Discovery & Development

A new nanoemulsion eye drop formulation of a small molecule RUNX1 inhibitor

November 30, 2020

Categories: Research, Drug Discovery & Development, Pharma

Kent Scientific introduces SomnoFlo™ Low-Flow electronic anesthesia vaporizer for small animals

November 17, 2020

Categories: Drug Discovery & Development, Corporate, Finance & Investor

Repositive expands global cancer model network with CRO from Finland

November 10, 2020